INSM
INSMED Inc
Key Financials
Operating Income
$-1246769000
↓ 42.0%
Net Income
$-1276775000
↓ 39.7%
Revenue
$606.4M
↑ 66.7%
Total Assets
$2.3B
↑ 11.8%
EPS (Diluted)
$-6.42
↓ 15.3%
Cash & Equivalents
$510.4M
↓ 8.0%
Total Liabilities
$1.5B
↓ 12.3%
Gross Profit
$112.3M
↑ 203.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/17/2026 | View on SEC |
| 144 | 4/16/2026 | View on SEC |
| 4 | 4/8/2026 | View on SEC |
| 8-K | 4/7/2026 | View on SEC |
| 144 | 4/6/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
| 144 | 4/1/2026 | View on SEC |
| ARS | 4/1/2026 | View on SEC |
| DEFA14A | 4/1/2026 | View on SEC |
| DEF 14A | 4/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | INSM |
| Company Name | INSMED Inc |
| CIK | 1104506 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | VA |
| Phone | 908-977-9900 |